T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
226
DELISTED
Blueprint Medicines
BPMC
| $633M | 0.08% |
5,873,392
-377,431
| -6% | -$37.8M |
|
227
Equity Lifestyle Properties
ELS
$12.4B
| $630M | 0.08% |
9,671,408
+97,291
| +1% | +$6.1M |
|
228
Cisco
CSCO
$488B
| $623M | 0.07% |
13,108,219
-750,286
| -5% | -$35.6M |
|
229
Boston Scientific
BSX
$74.5B
| $622M | 0.07% |
8,071,053
+888,893
| +12% | +$65.1M |
|
230
Alibaba
BABA
$300B
| $621M | 0.07% |
8,624,007
+268,879
| +3% | +$20.6M |
|
231
Idexx Laboratories
IDXX
$45B
| $619M | 0.07% |
1,270,882
+993,366
| +358% | +$499M |
|
232
Hubbell
HUBB
$27.1B
| $617M | 0.07% |
1,688,098
-292,358
| -15% | -$115M |
|
233
US Bancorp
USB
$101B
| $613M | 0.07% |
15,430,762
-1,111,566
| -7% | -$45.3M |
|
234
Bio-Techne
TECH
$11.3B
| $611M | 0.07% |
8,525,772
+2,779,653
| +48% | +$205M |
|
235
KE Holdings
BEKE
$19.2B
| $610M | 0.07% |
43,126,585
+4,762,947
| +12% | +$74.6M |
|
236
CVS Health
CVS
$121B
| $605M | 0.07% |
10,236,372
-462,662
| -4% | -$28.9M |
|
237
Viatris
VTRS
$18.5B
| $604M | 0.07% |
56,823,030
-1,061,401
| -2% | -$11.7M |
|
|
SEM
238
DELISTED
Select Medical
SEM
| $601M | 0.07% |
31,790,867
-136,451
| -0.4% | -$2.33M |
|
239
Regency Centers
REG
$13.9B
| $600M | 0.07% |
9,642,841
+594,088
| +7% | +$35.6M |
|
240
O'Reilly Automotive
ORLY
$74.5B
| $599M | 0.07% |
8,510,925
-202,185
| -2% | -$14M |
|
241
Trane Technologies
TT
$105B
| $597M | 0.07% |
1,814,537
-9,426
| -0.5% | -$3M |
|
242
Veeva Systems
VEEV
$39.2B
| $592M | 0.07% |
3,237,401
-2,450,566
| -43% | -$486M |
|
243
BILL Holdings
BILL
$4.85B
| $590M | 0.07% |
11,203,000
+156,628
| +1% | +$8.86M |
|
244
LPL Financial
LPLA
$29.7B
| $587M | 0.07% |
2,099,916
-274,885
| -12% | -$74.6M |
|
245
SiteOne Landscape Supply
SITE
$4.22B
| $585M | 0.07% |
4,816,232
+561,789
| +13% | +$84.9M |
|
246
Repligen
RGEN
$9.35B
| $581M | 0.07% |
4,608,433
+1,040,117
| +29% | +$163M |
|
247
GE HealthCare
GEHC
$32.6B
| $571M | 0.07% |
7,334,157
-2,627,361
| -26% | -$214M |
|
248
Samsara
IOT
$22.9B
| $571M | 0.07% |
16,941,610
-697,531
| -4% | -$24.1M |
|
249
DoorDash
DASH
$92.1B
| $562M | 0.07% |
5,168,501
-301,146
| -6% | -$36.3M |
|
250
monday.com
MNDY
$3.63B
| $562M | 0.07% |
2,334,232
-830,334
| -26% | -$175M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.